1072708-39-4 Usage
General Description
1-(6-(4-bromo-2-chlorophenyl)-3-(bromomethyl)-5-(4-chlorophenyl)furo[2,3-b]pyridin-2-yl)-2,2-dimethylpropan-1-one is a complex organic chemical compound that consists of a furo[2,3-b]pyridine core structure linked to a 1-one group and a 2,2-dimethylpropan-1-one side chain. The compound also contains various halogen substituents, including bromine and chlorine, attached to the phenyl rings. 1-(6-(4-bromo-2-chlorophenyl)-3-(bromomethyl)-5-(4-chlorophenyl)furo[2,3-b]pyridin-2-yl)-2,2-dimethylpropan-1-one may be used in pharmaceutical research or other chemical applications and may have potential biological activity due to its unique structure and halogen substituents. It is important to note that this compound should be handled and used with appropriate safety precautions due to its complex structure and potential chemical reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 1072708-39-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,7,2,7,0 and 8 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1072708-39:
(9*1)+(8*0)+(7*7)+(6*2)+(5*7)+(4*0)+(3*8)+(2*3)+(1*9)=144
144 % 10 = 4
So 1072708-39-4 is a valid CAS Registry Number.
1072708-39-4Relevant articles and documents
Substituted furo[2,3-B] pyridine derivatives as cannabinoid-1 receptor modulators
-
Page/Page column 30, (2008/12/04)
Novel compounds of the structural formula (I) are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment, prevention and suppression of diseases mediated by the CB1 receptor. The compounds of the present invention are useful as centrally acting drugs in the treatment of psychosis, memory deficits, cognitive disorders, Alzheimer's disease, migraine, neuropathy, neuro-inflammatory disorders including multiple sclerosis and Guillain-Barre syndrome and the inflammatory sequelae of viral encephalitis, cerebral vascular accidents, and head trauma, anxiety disorders, stress, epilepsy, Parkinson's disease, movement disorders, and schizophrenia. The compounds are also useful for the treatment of substance abuse disorders, the treatment of obesity or eating disorders, as well as the treatment of asthma, constipation, chronic intestinal pseudo-obstruction, cirrhosis of the liver, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and the promotion of wakefulness.